-+ 0.00%
-+ 0.00%
-+ 0.00%
Immedica's Hyperargininemia Drug Loargys Wins Approval in Saudi Arabia
Share
Listen to the news
07:32 AM EST, 11/16/2026 (MT Newswires) -- The Saudi Food and Drug Authority approved Sweden-based Immedica's hyperargininemia drug Loargys, or pegzilarginase. Loargys treats hyperargininemia in adults, adolescents, and children aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction, according to a Monday release.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending